{"protocolSection":{"identificationModule":{"nctId":"NCT01830517","orgStudyIdInfo":{"id":"HM-AMO-401"},"organization":{"fullName":"Hanmi Pharmaceutical Company Limited","class":"INDUSTRY"},"briefTitle":"Diurnal Variation in Hypertensive Stroke Patients","officialTitle":"Comparison of the Effects of Amlodipine and Losartan on Blood Pressure and Diurnal Variation in Hypertensive Stroke Patients"},"statusModule":{"statusVerifiedDate":"2013-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2007-08"},"primaryCompletionDateStruct":{"date":"2011-06","type":"ACTUAL"},"completionDateStruct":{"date":"2012-02","type":"ACTUAL"},"studyFirstSubmitDate":"2013-04-10","studyFirstSubmitQcDate":"2013-04-11","studyFirstPostDateStruct":{"date":"2013-04-12","type":"ESTIMATED"},"lastUpdateSubmitDate":"2013-04-11","lastUpdatePostDateStruct":{"date":"2013-04-12","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Hanmi Pharmaceutical Company Limited","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"This study was conducted to evaluate and compare the effectiveness of Amodipin® (amlodipine camsylate) with that of Cozaar® (losartan potassium) in hypertensive patients with an acute ischemic stroke by measuring their 24-hour ambulatory BP (ABP)."},"conditionsModule":{"conditions":["Hypertension","Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":84,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"amlodipine camsylate","type":"EXPERIMENTAL","description":"amlodipine camsylate 5mg","interventionNames":["Drug: Amlodipine, Losartan"]},{"label":"losartan potassium","type":"ACTIVE_COMPARATOR","description":"losartan potassium 50mg","interventionNames":["Drug: Amlodipine, Losartan"]}],"interventions":[{"type":"DRUG","name":"Amlodipine, Losartan","armGroupLabels":["amlodipine camsylate","losartan potassium"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"24-hour ambulatory mean SBP","timeFrame":"baseline and 8weeks"}],"secondaryOutcomes":[{"measure":"24H mean DBP, 24H mean SBP/DBP Variability,clinic SBP/DBP, awake, sleep, morning, evening, and prewake BPs, the morning surge, and the nocturnal dipping","timeFrame":"baseline and 8weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. aged 35 to 85 years\n2. hypertensive patients who had an ischemic stroke\n\nExclusion Criteria:\n\n1. patients aged below 35 years or above 86 years;\n2. patients who had a hemorrhagic stroke;\n3. patients whose systolic BP (SBP) was over 220 mmHg or whose diastolic BP (DBP) was above 120 mmHg during an acute phase, or whose SBP was over 180 mmHg or whose DBP was over 110 mmHg one week after their hospital visit;\n4. patients with secondary hypertension related to renovascular, endocrinologic, or pregnant conditions\n5. patients who went to bed in the middle of the day or very late at night; (6) patients who were using intravenous antico-agulants or thrombolytics;\n\n(7) patients with a severe stroke (NIH stroke scale \\> 20); (8) patients who could not give their consent to investigators; (9) patients with severely impaired liver function (AST or ALT ≥ 100); (10) patients with severely impaired renal function (serum creatinine ≥ 2.0 mg/dL); (11) patients with cancer; (12) patients who were pregnant or lactating; (13) patients with other grave diseases such as hypertensive encephalopathy, aortic dissection, acute myocardial infarction, or severe congestive heart failure; and (14) patients who were allergic to the test or control drugs","healthyVolunteers":false,"sex":"ALL","minimumAge":"35 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Hyunwoo Nam, M.D., Ph.D.","affiliation":"SMG-SNU Boramae Medical Center","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Boramae Medical Center","city":"Boramae-ro 5-gil 20, Dongjak-gu","state":"Seoul","zip":"156-707","country":"Korea, Republic of"}]},"referencesModule":{"references":[{"pmid":"24296324","type":"DERIVED","citation":"Kwon HM, Shin JW, Lim JS, Hong YH, Lee YS, Nam H. Comparison of the effects of amlodipine and losartan on blood pressure and diurnal variation in hypertensive stroke patients: a prospective, randomized, double-blind, comparative parallel study. Clin Ther. 2013 Dec;35(12):1975-82. doi: 10.1016/j.clinthera.2013.10.013. Epub 2013 Dec 2."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M9714","name":"Hypertension","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]},"interventionBrowseModule":{"meshes":[{"id":"D000019808","term":"Losartan"},{"id":"D000017311","term":"Amlodipine"}],"ancestors":[{"id":"D000000959","term":"Antihypertensive Agents"},{"id":"D000002121","term":"Calcium Channel Blockers"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000077264","term":"Calcium-Regulating Hormones and Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000014665","term":"Vasodilator Agents"},{"id":"D000000889","term":"Anti-Arrhythmia Agents"},{"id":"D000047228","term":"Angiotensin II Type 1 Receptor Blockers"},{"id":"D000057911","term":"Angiotensin Receptor Antagonists"}],"browseLeaves":[{"id":"M19290","name":"Amlodipine","asFound":"Step","relevance":"HIGH"},{"id":"M21391","name":"Losartan","asFound":"800","relevance":"HIGH"},{"id":"M3967","name":"Antihypertensive Agents","relevance":"LOW"},{"id":"M5071","name":"Calcium","relevance":"LOW"},{"id":"M5088","name":"Calcium, Dietary","relevance":"LOW"},{"id":"M5074","name":"Calcium Channel Blockers","relevance":"LOW"},{"id":"M9479","name":"Hormones","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"},{"id":"M3903","name":"Anti-Arrhythmia Agents","relevance":"LOW"},{"id":"M3822","name":"Angiotensin II","relevance":"LOW"},{"id":"M289298","name":"Giapreza","relevance":"LOW"},{"id":"M3825","name":"Angiotensinogen","relevance":"LOW"},{"id":"M25479","name":"Angiotensin II Type 1 Receptor Blockers","relevance":"LOW"},{"id":"M28606","name":"Angiotensin Receptor Antagonists","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnAg","name":"Antihypertensive Agents"},{"abbrev":"ChanBlk","name":"Channel Blockers"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"AnArAg","name":"Anti-Arrhythmia Agents"},{"abbrev":"BDCA","name":"Bone Density Conservation Agents"},{"abbrev":"VaCoAg","name":"Vasoconstrictor Agents"}]}},"hasResults":false}